Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Home
Akorn Gets Warning Letter from FDA
April 2, 2007
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
pharmamanufacturing
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Anticipating AI regulations in pharma manufacturing
FDA decisions to watch in 2024
Raising a modern pharma CDMO
2024 pharma predictions: Regulations, sustainability and culture
Pharma on top for employee pay satisfaction
Production Pulse: What's ahead for manufacturing in 2024?
Load More Content